Solitary Sequencing

Decoding the genome of a single cell could reveal previously overlooked levels of genetic variation.

Written byBeth Marie Mole
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Wikimedia, TenOfAllTradesGenome sequencing usually requires the pooled DNA from thousands, if not millions, of cells, but a new method allows researchers to sequence up to 93 percent of a genome from a single cell. The technique, published yesterday (December 20) in Science, will help scientists identify cell-specific sequence variation, which could, for example, clarify how individual cancer cells become more malignant, or how neurons differ.

“[This technique] opens a door to many critical questions,” geneticist Bing Ren of the University of California, San Diego, who was not involved in the study, told Nature.

To decode the genome of a single cell, researchers developed a DNA amplification process called multiple annealing and looping-based amplification cycles (MALBAC). The method allows scientists to create the ample copies of DNA needed for sequencing without over-copying certain regions that are easy to copy—a critical pitfall in sequencing small amounts of DNA. The trick is the addition of DNA primers—small DNA fragments that bind to single-stranded DNA and start the copying process—that have an extra DNA sequence attached. After parts of the genome have been copied, the extra sequences from the primers link together to form ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies